Dopamine agonists with structural similarity to 5-HT, such as pergolide and cabergoline, which are used in the treatment of Parkinson’s disease, are also associated with the development of fibrosis in heart valves involving 5-HT2B agonism [53]. Here, HTR5A is linked to Parkinson disease.